As a translational researcher, you’re paving an uncharted path toward exciting new possibilities in healthcare. There are likely to be unexpected and complex challenges to overcome along the journey driven by cutting-edge science and a pioneering spirit, but you aren’t facing them alone.
The Translational Scientist, an organization that reports on the people, processes, and vision that translate scientific discoveries into improved health, surveyed its audience to identify common roadblocks, and many responses shared similar themes.
Cytiva is now using these findings to develop the resources the translational community needs to bring innovative ideas to patients. Our “Hurdles and High Jumps” series includes informative articles written by thought leaders who have successfully partnered to bring preclinical concepts to clinical trials.
We hope to provide specialized, targeted support that fosters translational success and brings new therapies to patients in need by highlighting key lessons learned through diverse experiences.
In this article, explore five difficulties translational researchers face when developing a new therapy.